Talphera (TLPH) Restructuring Costs (2015)

Talphera (TLPH) recorded quarterly Restructuring Costs of $2000.0 in Q2 2015, down 99.73% quarter-over-quarter from $754000.0 in Q1 2015.

Talphera (TLPH) Restructuring Costs (2015) Analysis & Trends

Talphera's Restructuring Costs history runs 1 years deep, the most recent figure standing at $2000.0 for Q2 2015.

In Q2 2015, Restructuring Costs changed N/A year-over-year to $2000.0; the TTM figure through Dec 2015 stood at $756000.0 (changed N/A YoY), while the FY2015 annual figure was $756000.0, changed N/A from the prior year.
Restructuring Costs was $2000.0 for Q2 2015 at Talphera, down from $754000.0 in the prior quarter.
In the past five years, Restructuring Costs ranged from a high of $754000.0 in Q1 2015 to a low of $2000.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Talphera	59.35 Mn	59.35 Mn	-

Download Data

Date	Value
Jun 30, 2015	2,000.00
Mar 31, 2015	754,000.00